Göran Jönsson

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Pervasive chromosomal instability and karyotype order in tumour evolution”.

Pervasive chromosomal instability and karyotype order in tumour evolution

Nature(2020)10.1038/s41586-020-2698-6

N/A

7.1DataRank · unranked

405 citations

Emilia L. Lim, Marina Petković, Sergi Elizalde, Nicolai J. Birkbak, Gareth A. Wilson +50 more

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma

Molecular Oncology(2020)10.1002/1878-0261.12663

N/A

0DataRank · unranked

49 citations

Martin Lauss, Rita Cabrita, Jiyeon Choi, Tongwu Zhang, Karolin Isaksson +9 more

Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.24.961771

N/A

0DataRank · unranked

2 citations

Dominique‐Laurent Couturier, Jérémie Nsengimana, Nuno A. Fonseca, Matthew Wongchenko, Yibing Yan +11 more

Tumour gene expression signature in primary melanoma predicts long-term outcomes

Nature Communications(2021)10.1038/s41467-021-21207-2

N/A

0DataRank · unranked

70 citations

Dominique‐Laurent Couturier, Jérémie Nsengimana, Nuno A. Fonseca, Matthew Wongchenko, Yibing Yan +21 more

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

Journal of Clinical Investigation(2021)10.1172/jci129466

N/A

0DataRank · unranked

35 citations

Erez Greenstein, Michal Alon, Joy A. Pai, Tamir Dingjan, Shlomit Reich-Zeliger +26 more

BRN2 is a non-canonical melanoma tumor-suppressor

Nature Communications(2021)10.1038/s41467-021-23973-5

N/A

0DataRank · unranked

17 citations

Pierre Sohier, Valérie Petit, Jérémy H. Raymond, Véronique Delmas, Madeleine Le Coz +19 more

Transcriptomic signatures of tumors undergoing T cell attack

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-03015-1

N/A

0DataRank · unranked

8 citations

Aimilia Schina, Martin Lauss, Katja Harbst, Christopher A. Chamberlain, Arianna Draghi +10 more

BRN2 is a non-canonical melanoma tumor-suppressor

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.13.426554

N/A

0DataRank · unranked

0 citations

Pierre Sohier, Valérie Petit, Jérémy H. Raymond, Véronique Delmas, Madeleine Le Coz +18 more

Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006941

N/A

0DataRank · unranked

17 citations

Zsofia Sztupinszki, Inge Marie Svane, Zoltán Szállási, Göran Jönsson, Marco Donia +1 more

Data from Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma

(2023)10.1158/1078-0432.c.6527877

N/A

0DataRank · unranked

0 citations

Jonathan P. Laye, Martin Lauss, Joey Mark S. Diaz, Sally J. O’Shea, Joanna Poźniak +12 more

Functional characterization of the 9q34.13 locus identifies RAPGEF1 as modulating risk for melanoma and nevi via RAS activation

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.03.691936

N/A

0DataRank · unranked

0 citations

Mai Xu, Alexandra Thornock, Joshuah Yon, Samuel Anyaso‐Samuel, Martin Lauss +28 more